The Department of Health and Social Care (DHSC) has announced a consultation on changes to the Human Medicine Regulations designed to reduce risks for distribution of any COVID-19 vaccine alongside products for flu.
There is concern that the ongoing fight against the coronavirus pandemic will run into difficulties when flu season starts. It is hoped that a vaccine will soon be available for COVID-19, but regulation changes may be needed in order to ensure its distribution is efficient. DHSC said:
“The UK government is seeking views on proposals to make changes, in conjunction with the Minister of Health in Northern Ireland, to the Human Medicine Regulations 2012. These changes will support the effective rollout of a COVID-19 vaccine and the upscaling of influenza (flu) vaccination programme in the UK. It is important to emphasise, however, that although some of the measures specifically reference COVID-19 and flu vaccines, the proposed changes will also facilitate the efficient mass distribution of treatments for COVID-19, or for any other disease that poses a serious risk to public health.”
Supply chain and staff level issues are addressed in the proposals, as well as wholesaling.
Read the full consultation document and take part on the DHSC website.